What is a suitable tapering schedule for Ativan (lorazepam) for a person taking 3mg daily for 4 weeks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ativan (Lorazepam) Tapering Schedule for 3mg Daily Use Over 4 Weeks

For a patient on lorazepam 3mg daily for 4 weeks, taper by reducing 25% of the current dose every 1-2 weeks, completing discontinuation over approximately 6-8 weeks, as this duration of use represents relatively short-term exposure with lower risk of severe withdrawal compared to long-term users. 1

Recommended Tapering Protocol

Week-by-Week Schedule

Week 1-2: Reduce to 2.25mg daily (25% reduction from 3mg)

  • This represents the initial 25% reduction recommended by CDC guidelines 1
  • Monitor for mild withdrawal symptoms including anxiety, tremor, insomnia, or headache 1

Week 3-4: Reduce to approximately 1.5-1.75mg daily (25% reduction from current dose)

  • Continue reducing by 25% of the current dose, not the original dose, to prevent disproportionately large final reductions 1
  • The taper rate must be determined by patient tolerance, not rigid adherence to schedule 1

Week 5-6: Reduce to approximately 1-1.25mg daily

  • As you approach lower doses, consider slowing the taper if withdrawal symptoms emerge 1
  • Pauses in the taper are acceptable and often necessary when symptoms occur 1

Week 7-8: Reduce to 0.5mg daily, then discontinue

  • Once the smallest available dose is reached, you can extend the interval between doses before complete discontinuation 1
  • The FDA label recommends gradual tapering to reduce withdrawal risk 2

Critical Safety Considerations

Never discontinue abruptly - Abrupt cessation can cause seizures and death, making gradual tapering essential 1, 2

Benzodiazepine withdrawal carries greater risks than opioid withdrawal and must always be conducted gradually 1

If Patient is Also Taking Opioids

Taper the benzodiazepine first before addressing opioid reduction, as benzodiazepine withdrawal poses higher risks 1

Monitoring Requirements

Follow up weekly or biweekly during the taper to assess withdrawal symptoms and adjust the schedule as needed 1

Monitor specifically for:

  • Anxiety, tremor, insomnia, sweating, tachycardia 1
  • Headache, weakness, muscle aches, nausea 1
  • Confusion, altered mental status, or seizures (medical emergency) 1

Managing Withdrawal Symptoms

If withdrawal symptoms become intolerable:

  • Slow the taper rate to 10% reductions per month 3
  • Consider pausing the taper temporarily 2
  • May reinstate the previous dose level, then decrease more slowly 2

Adjunctive medications that may help:

  • Gabapentin 100-300mg at bedtime or three times daily, titrated cautiously to mitigate withdrawal symptoms 1
  • Carbamazepine may help, though evidence is limited 1
  • Short-term trazodone or gabapentin for insomnia and anxiety 3

Non-Pharmacological Support

Cognitive behavioral therapy (CBT) during the taper significantly increases success rates and should be offered if available 1

Additional supportive measures include:

  • Patient education about benzodiazepine risks and tapering benefits 1
  • Mindfulness and relaxation techniques 1
  • Sleep hygiene education 1

Important Caveats

This 6-8 week schedule is appropriate for 4 weeks of use. For patients on benzodiazepines longer than 1 year, extend the taper to 10% per month rather than 25% every 1-2 weeks 1

The taper may take longer than planned - success is measured by progress and durability, not speed 1

When to refer to a specialist immediately:

  • History of withdrawal seizures 1
  • Unstable psychiatric comorbidities 1
  • Co-occurring substance use disorders 1
  • Previous unsuccessful tapering attempts 1

Special Populations

Elderly or debilitated patients: Consider more gradual taper with smaller dose reductions (10% of current dose every 2-4 weeks) to minimize adverse effects 1

Pregnant patients: Do not taper without specialist consultation, as withdrawal can cause spontaneous abortion and premature labor 1

Key Pitfall to Avoid

Do not reduce by a fixed amount each time - always reduce by a percentage of the current dose, not the original dose, to prevent the final reductions from being disproportionately large and poorly tolerated 1

References

Guideline

Benzodiazepine Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cross-Tapering from Duloxetine to Venlafaxine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.